Rachael McLaughlin
Psychiatric/Mental Health · Maple Heights, OHNPI 1578905592
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $97,127 of the $113,927 with a category attached, or 85.3%. Alkermes, Inc. accounts for 68.6% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $43,064, more than ten times the $1,526 reported in 2021. Among psychiatric/mental health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 234 payments — averaging $486.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$78K
- AbbVie$26K
- Teva Pharmaceuticals USA, Inc.$9K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$123
- Biogen$115
- Indivior Inc.$24
What the payments were for
- Consulting fees$3,7103%
- Speaking & faculty fees$97,12785%
- Travel & lodging$7,5137%
- Food & beverage$5,5785%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 159 | $78,158 |
| AbbVie | 51 | $26,069 |
| Teva Pharmaceuticals USA, Inc. | 21 | $9,438 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $123 |
| Biogen | 1 | $115 |
| Indivior Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$113,927 in reported general payments places this provider in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LybalviOlanzapine/Samidorphan Malate | 101 | $156,978 |
| Invega SustennaPaliperidone Palmitate | 60 | $154,955 |
| VraylarCariprazine Hcl | 107 | $146,054 |
| AustedoDeutetrabenazine | 17 | $95,428 |
| Invega TrinzaPaliperidone Palmitate | 11 | $78,706 |
| AristadaAripiprazole Lauroxil | 19 | $58,134 |
| LatudaLurasidone Hcl | 35 | $56,831 |
| Abilify MaintenaAripiprazole | 12 | $33,156 |
| VyvanseLisdexamfetamine Dimesylate | 69 | $25,115 |
| Lurasidone Hcl | 123 | $21,370 |
| CaplytaLumateperone Tosylate | 22 | $16,721 |
| TrintellixVortioxetine Hydrobromide | 48 | $16,117 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 30 | $15,530 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 45 | $10,793 |
| Aripiprazole | 188 | $8,899 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Alkermes, Inc.Lybalvi, Aristada | $78,158 | $215,112120 claims |
| AbbVieVraylar | $26,069 | $146,054107 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $9,438 | $95,42817 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $123 | $16,72122 claims |
| Indivior Inc.Suboxone | $24 | $15,53030 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.
Other psychiatric/mental health in Maple Heights
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
- Danielle MorroneCanfield$94K
- Tamara ThornMoraine$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.